Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions.
about
Immune-phenotypical markers for the differential diagnosis of melanocytic lesionsResponse of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis.The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways.Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cellsDiethylentriaminepenta acetic acid glucose conjugates as a cell permeable iron chelator.CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma.Prognostic value of GLUT-1 expression in pancreatic cancer: results from 538 patients.Oxygen metabolism in oral cancer: HIF and GLUTs (Review)Evaluation of Hypoxia Inducible Factor-1α and Glucose Transporter-1 Expression in Non Melanoma Skin Cancer: An Immunohistochemical Study.Expression of GLUT-1 in oral squamous cell carcinoma in tobacco and non-tobacco usersGlucose availability controls ATF4-mediated MITF suppression to drive melanoma cell growth.Gd(3+)-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent.Immunohistochemistry: relevance in dermatology.FDG-PET is a good biomarker of both early response and acquired resistance in BRAFV600 mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973.Histidine residues in the Na+-coupled ascorbic acid transporter-2 (SVCT2) are central regulators of SVCT2 function, modulating pH sensitivity, transporter kinetics, Na+ cooperativity, conformational stability, and subcellular localization.Glucose transporter-1 as a new therapeutic target in laryngeal carcinoma.Expression of Glut-1 in Malignant Melanoma and Melanocytic Nevi: an Immunohistochemical Study of 400 Cases.Sweat glucose and GLUT2 expression in atopic dermatitis: Implication for clinical manifestation and treatment.
P2860
Q26776090-5186E663-D74F-4AED-B1A4-CA6859BFD9F4Q33946905-94BD4016-094B-482B-8186-15D56D587061Q34459021-26929843-1206-4B1F-BB77-0967953D07FDQ36544964-D26D8253-EC7A-488C-9E2D-0470CBE965AEQ37565866-EA1C284E-F71D-4AE8-9326-D834AFDD37A0Q37662131-59AE0410-6741-4D94-8E34-35CB3515DA65Q37746128-821DDF27-79EE-47B2-89EF-5EFB55ABACF5Q38153696-F79B202F-0BF4-4AB9-9B27-B59920106907Q38372657-BF162E0A-A74E-4942-BE8A-B446B71819B0Q38517968-04FCA9F7-1675-486B-8DA2-92407E2255CDQ38852351-B5D6468E-256C-44F3-9813-126DE2832ADCQ39540783-B13DBA13-FC1A-42FD-9AB3-FE938CD2FBC2Q41006365-29F6DB15-2DF7-43E4-AEAE-31D84A8784F8Q42250522-3796344D-8307-46F7-A561-A8F4BBF9FE45Q42369917-B3DFDBEE-779E-4FDF-BAC0-AECC9BD81AC5Q42758534-84A5FCF4-D773-4610-9DF0-56FA7BFE7568Q47612204-EA749F96-5DAE-490F-B2E3-80927F5EB5DBQ52574405-208A4A33-0493-45B7-A246-539BEDAC292C
P2860
Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Immunohistochemical expression ...... nd benign melanocytic lesions.
@en
type
label
Immunohistochemical expression ...... nd benign melanocytic lesions.
@en
prefLabel
Immunohistochemical expression ...... nd benign melanocytic lesions.
@en
P2093
P2860
P356
P1476
Immunohistochemical expression ...... nd benign melanocytic lesions.
@en
P2093
Antonella Coli
Antonella Mangoni
Giulio Bigotti
Guido Massi
Manuela M Fabrizi
Paola Parente
P2860
P2888
P356
10.1186/1756-9966-27-34
P577
2008-09-02T00:00:00Z
P5875
P6179
1029222913